Avance Medical is the first company to develop fully automated systems to produce autologous bio-regenerative fibrin (BRF). We process the patient’s own blood during a surgical procedure in the operating room to produce a fibrin rich in clotting factors to stop bleeding. The fibrin also has anti-microbial properties especially effective against super bugs like MRSA being the major culprit for hospital acquired infections. Further the fibrin contains growth factors vital for regenerating connective tissues and facilitate wound homeostasis and healing. Avance is conducting a number of studies showing promising results in achieving these objectives.

Innovating Open-Heart Surgery

Eliminating Donor Blood Transfusions and Infections

  • Reducing blood loss
  • Reducing deep sternal infections
  • Reducing tissue regeneration and wound healing complications